Terms ending in 2028
Every in-force patent on MicroVention, Inc.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,707,281 | Thermal Detachment System For Implantable Devices In force · Low confidence | MicroVention, Inc. | In force | Low confidence | |
| US 9,259,228 | Embolization Device Constructed from Expansile Polymer In force · High confidence | Microvention, Inc. | In force | High confidence | |
| US 9,259,337 | Methods and Devices for Treatment of Vascular Defects In force · Medium confidence | Microvention, Inc. | In force | Medium confidence | |
| US 12,702,422 | Detachable Coil Incorporating Stretch Resistance In force · Medium confidence | MicroVention, Inc. | In force | Medium confidence | |
| US 11,045,205 | Detachable Coil Incorporating Stretch Resistance In force · Medium confidence | MicroVention, Inc. | In force | Medium confidence | |
| US 11,918,230 | Detachable Coil Incorporating Stretch Resistance In force · Medium confidence | MicroVention, Inc. | In force | Medium confidence | |
| US 8,470,035 | Hydrogel Filaments for Biomedical Uses In force · High confidence | Microvention, Inc. | In force | High confidence | |
| US 10,194,915 | Implantation Devices Including Hydrogel Filaments In force · High confidence | Microvention, Inc. | In force | High confidence | |
| US 11,179,159 | Methods and Devices for Treatment of Vascular Defects In force · High confidence | Microvention, Inc. | In force | High confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.